ANIK Q3 2017 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$208M

Q3 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$27M+5.4% YoY

Gross Profit

$21M77.0% margin

Operating Income

$10M37.8% margin

Net Income

$7M25.3% margin

EPS (Diluted)

$0.46

QoQ Revenue Growth

-18.8%

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$273M

Total Liabilities

$20M

Stockholders' Equity

$253M

Cash & Equivalents

$127M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$26M	+5.4%
Gross Profit	$21M	$21M	+0.7%
Operating Income	$10M	$14M	-25.0%
Net Income	$7M	$9M	-23.1%

Geographic Segments

UNITED STATES

$22M89%

Europe

$3M11%